Clinical Software in Illinois

Inventex Medical is a privately held injection molding manufacturer specializing in custom medical device manufacturing for Class 1 and Class 2 devices. The company offers end-to-end services including injection mold design and tooling, custom injection molding for complex medical parts, rapid prototyping using advanced 3D metal printing, contract manufacturing, product development, assembly, packaging, and international sourcing. With 30+ years of experience in the medical industry, Inventex provides Comprehensive Product Responsibility (CPR) oversight that guides projects from concept through delivery, encompassing design optimization, manufacturability analysis, regulatory testing support, and full-scale production runs. The company operates under ISO 13485:2016 and ISO 9001:2015 certifications, maintains FDA registration, complies with 21 CFR Part 820, and implements Six Sigma quality control processes. Inventex combines American engineering with international sourcing capacity through an Asia-based purchasing office and maintains multiple manufacturing locations to support varying quality standards and cost requirements. Primary markets include electronics components, labware equipment, and pharmaceutical packaging sectors.

Endotronix is a cardiovascular medical device company specializing in remote hemodynamic monitoring systems for heart failure management. The company manufactures the Cordella PA Sensor and HF System, an FDA-approved implantable pulmonary artery pressure sensor designed for patients with NYHA class III heart failure. The Cordella system enables proactive, remote monitoring by collecting daily pulmonary artery pressure data alongside vital signs including blood pressure, weight, heart rate, and blood oxygen saturation. The integrated HF management platform provides clinicians with comprehensive, trended health data to guide medication optimization and reduce hospitalizations. Clinical evidence demonstrates the system achieved a 73% reduction in heart failure hospitalization rates at 12 months and a low 12-month hospitalization/all-cause mortality rate (0.36) in the PROACTIVE-HF trial. The platform combines patient-facing monitoring tools with clinician-directed workflows that align with care delivery models and support reimbursement. The company holds FDA approval for the Cordella system and focuses on advancing guideline-directed medical therapy adoption. Endotronix was acquired by Edwards Lifesciences in 2024 for $1.2 billion, integrating its hemodynamic monitoring technology into a major cardiovascular device portfolio.

Integrated Medical Systems, Inc. is a medical equipment distributor and service provider specializing in home infusion therapy, respiratory equipment, and enteral delivery devices. The company operates as a multi-service medical supplier offering rental, lease, and sales options for infusion pumps, IV poles, transfer devices, and wound care consumables under the IMed brand. Core business segments include equipment rentals tailored to treatment protocols and budget constraints; ISO-certified biomedical servicing and repair as a cost-effective alternative to in-house maintenance; asset management software (iQuest) providing real-time tracking and location monitoring of medical equipment; and cleanroom product consulting with USP 797 and USP 800-compliant supplies for controlled pharmacy environments. The company serves home infusion providers, healthcare facilities, and ambulatory care settings. Featured products include IMed EZ-FLOW infusion pumps (100mL and 270mL configurations at variable flow rates), IV poles (steel and disposable models), mini transfer pins, and elastic net tubular bandages in multiple sizes. The company maintains distribution operations and appears to serve national markets based on closure announcements for multiple locations. Services emphasize cost-effective equipment upkeep, regulatory compliance for compounded sterile preparations, and integrated asset visibility for hospital and infusion clinic operations.

Richard Wolf GmbH is a leading international manufacturer of minimally invasive surgical instruments and endoscopic system solutions. Founded in 1906 and headquartered in Germany, the company operates through 18 global branches and 130 distributors, employing over 1,700 personnel. Richard Wolf specializes in comprehensive endoscopic product portfolios and integrated operating theatre systems for multiple medical disciplines. The company serves urology, visceral surgery, gynecology, orthopedic/arthroscopic surgery, thoracic surgery, laryngology, spinal surgery, proctology, pediatrics, and shock wave therapy applications. Core product offerings include flexible and rigid endoscopes, laparoscopic instruments, arthroscopic systems, specialized surgical tools, and the integrated operating theatre solution "core nova." All instruments are engineered for compatibility, durability across multiple sterilization cycles, and ease of reprocessing in central sterile supply departments (CSSD). Richard Wolf provides full-service support including equipment financing, on-site service, collection service, repairs, spare parts, and replacement/loan devices. The company emphasizes ergonomic design, intuitive handling, and user-friendly concepts developed in collaboration with leading medical professionals and scientists. Products meet stringent international regulatory standards and are designed for minimal patient trauma and optimal clinical outcomes. The company also offers custom B2B solutions and integrated system concepts for healthcare organizations. Additionally, Richard Wolf leverages its endoscopic expertise for aerospace and industrial turbine inspection and maintenance applications.

Carematix is an AI-driven Remote Patient Monitoring (RPM) platform specializing in chronic care management and reimbursement optimization. The company provides FDA-cleared, cellular-enabled biometric devices (blood pressure monitors, weight scales, pulse oximeters, glucometers) paired with intelligent cloud-based software for care coordination and patient engagement. Carematix is the only RPM company audited by the FDA, combining hardware and software for seamless EMR integration and HIPAA-compliant workflows. The platform supports Remote Patient Monitoring (CPT codes 99453, 99454, 99457, 99458, 99445, 99470) and Advanced Primary Care Management (APCM) reimbursement, enabling healthcare providers to generate recurring revenue while reducing hospital readmissions and ER visits. Devices feature cellular connectivity (no Bluetooth pairing required), proprietary Guest Button functionality, and automated patient engagement through phone call reminders and customizable vital sign alerts. Carematix serves primary care practices, health systems, clinical trial sponsors, and specialty providers managing hypertension, heart failure, diabetes, and weight management. The platform has been deployed in clinical trials across 14 countries and supported by major healthcare organizations including Ochsner Health, Veterans Affairs, Novartis, and Innovaccer. Strong clinical evidence demonstrates improved blood pressure control, reduced 30-day hospital readmissions (40% reduction reported by Ochsner), enhanced patient compliance, and increased treatment satisfaction.

Neelyx Labs is a CLIA-certified clinical laboratory providing end-to-end testing infrastructure and services for population health programs. The company specializes in custom-branded at-home test kit development, laboratory analysis, and digital health integration serving public health agencies, health plans, digital health companies, employers, and research organizations. Capabilities include kit design and fulfillment with prepaid return logistics, multilingual support (12+ languages), high-complexity laboratory testing with rapid turnaround (24-hour average result delivery), electronic result reporting, and chain-of-custody management. Neelyx operates a white-label laboratory model, enabling digital health companies and health plans to offer branded testing experiences while outsourcing testing operations. The company provides program design consultation, workflow optimization, regulatory navigation support, and proprietary software platforms for ordering, tracking, results delivery, and population health dashboards. Neelyx has shipped 500,000+ kits and can launch new programs in under six weeks. Service markets include community screening, disease surveillance, workplace wellness, return-to-work protocols, and clinical research. The company positions itself as mission-driven toward community health and public health priorities, with dedicated account management and full-stack operational responsibility rather than transactional mega-lab services.

Prolaio Inc. is an FDA-cleared software platform designed to unite patients, care teams, and clinical researchers in cardiology through secure, technology-enabled data collection and analysis. The company develops real-world clinical data solutions specifically focused on heart disease management and drug development acceleration. Prolaio's platform collects continuous, high-density on-body patient data and applies advanced machine learning algorithms to synthesize meaningful clinical insights for treatment decisions and research optimization. The platform serves three primary user groups: patients receiving continuous heart health monitoring integrated with their care teams, care teams making longitudinal treatment decisions based on synthesized clinical data, and clinical researchers seeking high-density datasets to optimize study design and reduce trial overhead. The company has developed 40+ proven algorithms with 5 FDA-cleared algorithms currently deployed. Prolaio has accumulated over 4 million hours of on-body patient data across operations in 26+ countries. The company holds 20+ issued patents in machine learning and clinical data analytics. With 30+ years of cumulative machine learning expertise embedded in its platform, Prolaio addresses the significant clinical and economic burden of heart disease—the leading cause of death in the United States and responsible for 1.3 million preventable hospitalizations annually. The platform is designed to accelerate cardiology breakthroughs, improve patient outcomes, and streamline clinical research workflows by providing actionable, real-world clinical intelligence.

ARxIUM is a global leader in pharmacy automation and workflow solutions with over 30 years of experience enhancing pharmacy operations. Headquartered in Winnipeg, Manitoba and Buffalo Grove, Illinois, ARxIUM serves health systems, long-term care facilities, retail, and hospital pharmacies worldwide. The company specializes in end-to-end medication management automation, inventory optimization, and pharmacy workflow digitalization. Core offerings include robotic IV compounding automation (RIVA System), central fill and mail-order solutions, automated dispensing cabinet networks, medication packaging and vial filling systems, and a comprehensive inventory management platform with real-time visibility and performance analytics. ARxIUM's solutions address critical pharmacy challenges including medication safety, operational efficiency, compliance tracking (DSCSA), waste reduction, and cost optimization through intelligent automation and seamless system integration.

Physician Software Systems develops a SaaS-based clinical decision support platform for precision dosing of medications with narrow therapeutic indices, with initial focus on erythropoietic stimulating agent (ESA) management for hemodialysis patients. The proprietary, Mayo Clinic-derived platform leverages patented algorithms and physiological modeling to deliver individualized dosing recommendations, reducing hemoglobin variability, minimizing drug costs, and improving patient outcomes. The system integrates seamlessly with existing electronic medical records (EMRs) to streamline clinician workflows, reduce manual calculation burden, and provide system-wide visibility across large patient populations. PhySoft's evidence-based approach is particularly valuable for tough-to-titrate drugs requiring frequent dose adjustments and complex clinical evaluation.

LuxCreo Inc. is a dental technology company headquartered in Chicago, Illinois, specializing in high-speed 3D printing systems and integrated digital dentistry solutions. The company manufactures the iLux Pro Dental, claimed as the #1 dental 3D printer globally, alongside post-processing equipment (iLuxWash Dental automated cleaning and iLuxCure Pro Dental UV curing units). LuxCreo's product portfolio includes direct-printed orthodontic aligners (4D Aligner™, 4D Bright™), prosthodontic devices (nightguards, flexible partial dentures, dentures), restorative solutions (crowns, bridges, inlays/onlays), and dental models. The company develops proprietary materials including ActiveMemory™ Polymer, a shape-memory resin designed for superior patient comfort in clear aligner therapy. LuxCreo's software ecosystem comprises LuxFlow Pro (3D printing preparation), LuxDesign (AI-powered design automation), LuxLink (fleet management and monitoring), and LuxCloud Dental (integrated digital dentistry platform). Services include 4D Express™ (aligner design and manufacturing), installation and training, and technical support. The company serves both chairside clinical practices and laboratory-scale operations, with markets spanning North America, Europe, and APAC. LuxCreo positions itself at the intersection of clinical dentistry and manufacturing automation, targeting orthodontists, prosthodontists, and dental laboratories seeking to integrate digital workflows and same-day device fabrication.

A-S Medication Solutions (ASM) is a privately owned pharmaceutical company based in Fremont, Nebraska, founded in 1968. ASM specializes in point-of-care medication dispensing, pharmacy management, and wholesale pharmaceutical distribution serving over 3,600 provider dispensing sites. The company operates on-site closed system pharmacies and offers prepackaged medications tailored to clinic specifications, web-based pharmacy management systems, and secure pharmaceutical logistics. ASM emphasizes medication adherence and safety through automated dispensing technologies that reduce errors and improve dosage accuracy. Services include point-of-care dispensing with direct sourcing from manufacturers (85%+ direct), clinical program integration, comprehensive pharmacy solutions with automation and inventory management, and home delivery programs for mail-order medications. The company maintains FDA and DEA registrations in all 50 states, NABP VAWD accreditation, and Drug Distributor Accreditation. Target customers include healthcare providers, clinics, employer health clinics, and urgent care settings across the United States.

Blue Sky Bio, LLC is a manufacturer and distributor of high-quality dental implant systems and related products, founded in 1998 and based in Libertyville, Illinois. The company specializes in providing compatible implant systems, advanced digital planning software, surgical and clinical equipment, and prosthetic accessories at competitive pricing. Blue Sky Bio operates with a lean business model that minimizes traditional sales and marketing expenses, redirecting resources toward superior engineering and manufacturing. The company offers four implant systems on a unified prosthetic platform, supplemented by Blue Sky Plan—a comprehensive software solution for surgical guide design, implant planning, and case management. Additional services include LabPronto laboratory case submissions with fast turnaround, comprehensive digital dentistry education through Blue Sky Bio University, and clinical support from experienced practitioners. Blue Sky Bio serves value-conscious dental practitioners and laboratories seeking quality implant solutions and workflow efficiency.

Lattice Solutions provides patient safety software solutions focused on positive patient identification (PPID) across multiple clinical workflows. The company's flagship product, Lattice MediCopia, automates specimen collection labeling, transfusion administration tracking, infant feeding identification, medication administration verification, and anatomical pathology specimen tracking. The platform enables bedside printing of specimen labels and ensures accurate matching of blood products, breast milk, formula, patient meals, and medications to the correct patient and clinical orders. Lattice Solutions holds TRM (Transfusion Risk Management) approval for VA hospitals and maintains a CAGE code (8CMX6) and Unique Entity ID (G7CXVJ4YQ781), indicating federal contracting eligibility and compliance with procurement standards. The software is designed to enhance both quality assurance and operational productivity for nursing and phlebotomy departments by reducing identification errors and streamlining workflow automation.

Vantive is an independent healthcare company specializing in vital organ therapies, with a 70-year legacy in kidney care products and services. The company develops and markets dialysis equipment, continuous renal replacement therapy (CRRT) systems, and extracorporeal carbon dioxide removal (ECCO2R) technology for acute care settings. Vantive's product portfolio includes peritoneal dialysis systems such as HomeChoice, hemodialysis platforms, and advanced therapies like PrismaLung+ for ARDS management. The company serves chronic kidney disease patients and acute care settings through three integrated pillars: therapies (innovative medical devices for kidney and organ support), digital solutions (software platforms to optimize care quality and efficiency), and advanced services and education (clinician training and patient support programs). Vantive operates across home-based therapies, in-center dialysis, and acute care markets. The company emphasizes coordinated care ecosystems and patient-centric treatment options including home dialysis modalities. Manufacturing and R&D capabilities support clinical research and regulatory submissions. Vantive prioritizes evidence-based innovation with publications in peer-reviewed journals and presentations at major nephrology conferences. The organization serves patients, caregivers, and clinical teams with comprehensive support resources and medical information services.